About American Cell Technology
Home »
Why American Cell Technology?
American Cell Technology (ACT) provides a safe and trusted environment to store personal stem cells with the highest standards. Whether storing stem cells from the birth of a new family member or banking your own adult stem cells from adipose or bone marrow, American Cell Technology utilizes proprietary technology, in a FDA registered, current good tissue practice (cGTP) facility to safely store your cells.
Doctors and scientists continue to advance this field. Your own cells, with your own DNA have limitless potential as regenerative medicine continues to evolve. American Cell Technology grows potentially billions of your own cells in a sterile environment, cryopreserves (freezes in liquid nitrogen) those cells in the highest standards, making them available when requested in the future.
Your Personal Cells
Store your own cells, with your own DNA, only available for you – eliminating the risk of rejection of foreign DNA.
Trusted By Thousands
Join the ACT family through safely storing your youngest cells and having access to these cells throughout your life.
FDA Registered
ACT works with top medical practitioners with varying specialties across the US that trusts ACT in banking their patients’ cells
Quality Controlled
ACT uses proprietary technology and the highest quality media when working with your cells.
Meet Our Chief Scientific Officer
Elena Rusyn MD, PhD
Dr. Elena Rusyn is a medical scientist dedicated to enhancing the quality and extending the length of the human lifespan. She is Board Certified in Anti-Aging and Regenerative Medicine and has more than 15 years of experience in stem cell research and over 25 years of medical and clinical research training.
Elena has an MD from the prestigious medical school of Bogomolets National Medical University in Kiev, Ukraine. She completed her residency in Allergy and Immunology at the Academy of Postdoctoral Medical Training in Kiev. She continued her medical research and earned a doctorate in Allergy and Immunology with a subspecialty in Clinical Cardiology.
After moving to the United States, Elena completed postdoctoral training at the University of North Carolina, Chapel Hill, which was followed by two years at Harvard Medical School/Massachusetts General Hospital followed by one year at Gray Cancer Institute, London, UK and five years at Duke University Medical Center.
She spent a considerable amount of time developing expertise in the areas of anti-aging and regenerative medicine, woman’s health, autoimmune disorders, nutrition, stem cell research, along with neurodegenerative and metabolic disorders. Her work has been published in high impact peer-reviewed journals such as the Journal of Cell Biology, Oncogene, Cancer Research, Cell Host and Microbe, Nutrition and Cancer, Pediatric Research and Journal of Immunology and Allergy.
Elena Rusyn
FDA approved stem cell uses
0
+
Stem Cell Clinical Trials
0
+
Only 1 person with your unique DNA
0
Want to see if stem cell banking is right for you, call ACT for a free consultation
Clinical Trials Using Stem Cells Currently Underway
Clinical Studies using stem cells for various treatments are currently being conducted and can be found on Clinicaltrials.gov, where study sponsors submit information about their study to Clinicaltrials.gov and is responsible for the safety, science, and accuracy of any study they list.
Clinicaltrials.gov is a website and online database of clinical research studies and their results, maintained by The National Library of Medicine (NLM). A broad range of public and private organizations around the world sponsor (oversee) and fund (pay the costs) studies listed in the Clinicaltrials.gov database. U.S. government agencies neither oversee nor fund all the studies listed on ClinicalTrials.gov. AMERICAN CELL TECHNOLOGY DOES NOT PROMOTE THE USE OF STEM CELLS FOR ANY SPECIFIC TREATMENT INDICATIONS. POTENTIAL TREATMENT USES SHOULD BE DISCUSSED BETWEEN THE PATIENT AND THEIR PHYSICIAN.
Clinicaltrials.gov is a website and online database of clinical research studies and their results, maintained by The National Library of Medicine (NLM). A broad range of public and private organizations around the world sponsor (oversee) and fund (pay the costs) studies listed in the Clinicaltrials.gov database. U.S. government agencies neither oversee nor fund all the studies listed on ClinicalTrials.gov. AMERICAN CELL TECHNOLOGY DOES NOT PROMOTE THE USE OF STEM CELLS FOR ANY SPECIFIC TREATMENT INDICATIONS. POTENTIAL TREATMENT USES SHOULD BE DISCUSSED BETWEEN THE PATIENT AND THEIR PHYSICIAN.
